Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8(+) T-cell Recognition of a Retroviral Antigen
dc.contributor.author
Probst, Philipp
dc.contributor.author
Kopp, Janine
dc.contributor.author
Oxenius, Annette
dc.contributor.author
Colombo, Mario P.
dc.contributor.author
Ritz, Danilo
dc.contributor.author
Fugmann, Tim
dc.contributor.author
Neri, Dario
dc.date.accessioned
2017-11-08T12:24:42Z
dc.date.available
2017-10-06T02:47:05Z
dc.date.available
2017-11-08T12:24:42Z
dc.date.issued
2017-07
dc.identifier.issn
0008-5472
dc.identifier.issn
1538-7445
dc.identifier.other
10.1158/0008-5472.CAN-16-2946
en_US
dc.identifier.uri
http://hdl.handle.net/20.500.11850/191042
dc.language.iso
en
en_US
dc.publisher
American Association for Cancer Research
en_US
dc.title
Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8(+) T-cell Recognition of a Retroviral Antigen
en_US
dc.type
Journal Article
dc.date.published
2017-05-08
ethz.journal.title
Cancer Research
ethz.journal.volume
77
en_US
ethz.journal.issue
13
en_US
ethz.journal.abbreviated
Cancer Res
ethz.pages.start
3644
en_US
ethz.pages.end
3654
en_US
ethz.grant
Understanding and Exploiting the Molecular Targeting of Tumor Neo-vasculature
en_US
ethz.identifier.wos
ethz.identifier.scopus
ethz.publication.place
Philadelphia, PA
en_US
ethz.publication.status
published
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02030 - Dep. Biologie / Dep. of Biology::02520 - Institut für Mikrobiologie / Institute of Microbiology::03625 - Oxenius, Annette / Oxenius, Annette
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02030 - Dep. Biologie / Dep. of Biology::02520 - Institut für Mikrobiologie / Institute of Microbiology::03625 - Oxenius, Annette / Oxenius, Annette
ethz.grant.agreementno
163479
ethz.grant.fundername
SNF
ethz.grant.funderDoi
10.13039/501100001711
ethz.grant.program
Exzellenzbeitrag in Lebenswissenschaften
ethz.date.deposited
2017-10-06T02:47:26Z
ethz.source
WOS
ethz.eth
yes
en_US
ethz.availability
Metadata only
en_US
ethz.rosetta.installDate
2017-11-08T12:24:44Z
ethz.rosetta.lastUpdated
2022-03-28T18:00:56Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=Sarcoma%20Eradication%20by%20Doxorubicin%20and%20Targeted%20TNF%20Relies%20upon%20CD8(+)%20T-cell%20Recognition%20of%20a%20Retroviral%20Antigen&rft.jtitle=Cancer%20Research&rft.date=2017-07&rft.volume=77&rft.issue=13&rft.spage=3644&rft.epage=3654&rft.issn=0008-5472&1538-7445&rft.au=Probst,%20Philipp&Kopp,%20Janine&Oxenius,%20Annette&Colombo,%20Mario%20P.&Ritz,%20Danilo&rft.genre=article&rft_id=info:doi/10.1158/0008-5472.CAN-16-2946&
Files in this item
| Files | Size | Format | Open in viewer |
|---|---|---|---|
|
There are no files associated with this item. |
|||
Publication type
-
Journal Article [132204]